Using hierarchical clustering in the plasma samples cohort, we found significant promoter hypermethylation of eight genes (APC, BIN1, BRCA1, CST6, GSTP1, P16, P21 and TIMP3) in patients' plasma of breast cancer patients compared with plasma of normal subjects (Fig. 2a). This evidence concerns the gene BRCA1 and breast carcinoma.